Trade KYTX stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Kyverna Therapeutics, Inc. (KYTX) is trading at US$7.13, up 1.28% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$520.72M. Over the past 52 weeks, KYTX has traded between US$5.27 and US$13.67. On Syfe you can trade KYTX with $0 commission and add it to your watchlist.
| Previous close | US$7.04 |
|---|---|
| Market cap | US$520.72M |
| 52-week range | US$5.27 – US$13.67 |
| Volume | 960.24K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.
Year: 2024
Kyverna Therapeutics Names Greg Martini CFO
May 18, 12:48 PM · MT Newswires
Top Premarket Gainers
Apr 22, 11:34 AM · MT Newswires
Kyverna Therapeutics Files $300 Million Mixed Shelf
Mar 26, 9:29 PM · MT Newswires
Kyverna Therapeutics, Inc. (KYTX) stock is trading at US$7.13, +1.28% from the previous close of US$7.04.
The market cap for Kyverna Therapeutics, Inc. (KYTX) stock is approximately US$520.72M.
The 52-week high for Kyverna Therapeutics, Inc. (KYTX) stock is US$13.67.
The 52-week low for Kyverna Therapeutics, Inc. (KYTX) stock is US$5.27.
Kyverna Therapeutics, Inc. (KYTX) does not currently pay a dividend.
Stay on top of KYTX
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
